Skip to main content
OpenTrials
Completed

NCT Number: NCT02094196

The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders

The aim of this project is to assess reward- based learning behavior and its association with alterations in dopaminergic and glutamatergic transmission in detoxified alcohol-dependent patients and matched controls.

The investigators will explore how these alterations interact with clinical and psychosocial factors which can modify the relapse risk and learning deficits.

Patients will be detoxified in an inpatient setting. Clinical assessments, behavioral paradigms of learning and brain imaging will be carried out within at least 4 half- lives after any psychotropic medication.

The investigators will implement and apply functional imaging paradigms assessing Pavlovian-to-instrumental transfer and reversal learning tasks and associate model parameters of learning with alcohol craving, intake and prospective relapse risk.

In this project, the impact of the dopamine x glutamate interaction on learning deficits and consecutive relapse probability is targeted with [18F]fallypride PET and the measurement of absolute concentrations of glutamate with magnetic resonance spectroscopy (MRS).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Charité - Universitätsmedizin Berlin, Berlin, Germany

Loading trial locations.

About this study

Alcohol consumption despite negative consequences may rely on impaired flexibility in adapting the behavior to environmental changes, i.e. learning in response to reward contingencies. This learning deficit is of clinical relevance particularly during therapy and for the psychosocial outcome.

The reduced availability of central dopamine D2-receptors in detoxified alcohol dependent patients observed in PET investigations and their hypothetical effects on reward-related learning are in line with evidence for learning deficits in hypodopaminergic states, particularly for avoidance learning in non-dependent samples. Growing evidence indicates that the learning-related striatal dopamine signals are modulated by higher executive functions involving, e.g., the prefrontal cortex.

Here, broad glutamatergic outputs of the prefrontal cortex are crucial for subcortical learning mechanisms and match with recent models of interactive dopamine-glutamate dysfunctions and models of neurotrophic signaling in alcohol dependence.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Alcohol dependence according to DSM-IV
  • Minimum of 72 hours of abstinence, maximum of 21 days of abstinence
  • Minimum of three years of alcohol dependence
  • Low severity of withdrawal symptoms
  • Ability to provide fully informed consent and to use self- rating scales

Exclusion criteria

  • Lifetime history of DSM- IV bipolar or psychotic disorder
  • Current threshold DSM-IV diagnosis of any following disorders: current major - depressive disorder, generalized anxiety disorder, PTSD, borderline personality disorder or obsessive- compulsive disorder
  • History of substance dependence other than alcohol or nicotine dependence

Treatment and study plan

Alcohol detoxification

Other

Detoxified alcohol- dependent patients in an inpatient setting

Other names: Alcohol- dependent patients

Primary outcomes

  1. Striatal D2-receptor availability (PET) and prefrontal glutamate concentration (MRS)

    Time frame: first assessment time point (alc. dependent pat. up to 21 days after detoxification)

    reduction in striatal D2-receptor availability and a increase in prefrontal glutamate concentration in alcohol-dependent patients compared to healthy controls

Secondary outcomes

  1. behavioral data in reward-habit-learning paradigms

    Time frame: first assessment time point (alc. dependent pat. up to 21 days after detoxification)

    Reduced learning speed and PIT withdrawal score in the probabilistic reversal learning task

  2. Treatment response

    Time frame: 12-month follow-up period beginning after first assessment timepoint

    test the predictive effects of striatal D2-receptor availability and prefrontal glutamate availability for treatment outcome (relapse vs abstinence) in alcohol-dependent patients

Other outcomes

  1. striatal-prefrontal connectivity (fMRI)

    Time frame: first assessment time point (alc. dependent pat. up to 21 days after detoxification)

    striatal-prefrontal connectivity (see other LeAD-projects) in the probabilistic reversal learning task

Sponsors and collaborators

Lead sponsor

Technische Universität Dresden

Other

Collaborators

  • Charite University, Berlin, Germany

Registry information

Official study title

The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders (LeAD P5)

Acronym: LeADP5

Important dates

Study start
2012
Primary completion
2018
Study completion
2018
First posted
Mar 21, 2014
Registry last updated
Jul 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.